Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/144798
Title: | Where is the 'global' in the European Union's Health Research and Innovation Agenda? |
Author: | Berner-Rodoreda, Astrid Rehfuess, Eva Annette Klipstein-Grobusch, Kerstin Cobelens, Frank Raviglione, Mario Flahaut, Antoine Casamitjana, Núria Fröschl, Günter Skordis-Worral, Jolene Abubakar, Ibrahim Ashrafian, Hutan Agardh, Anette Visser, Leo Schultsz, Constance Plasència, Antoni Jahn, Albrecht Norton, Robyn van Leeuwen, Remko Hagander, Lars Bärnighausen, Till |
Keywords: | Salut Europa Recerca Health Europe Research |
Issue Date: | 2019 |
Publisher: | BMJ Publishing Group Ltd |
Abstract: | Global Health has not featured as prominently in the European Union (EU) research agenda in recent years as it did in the first decade of the new millennium, and participation of low-income and middle-income countries (LMICs) in EU health research has declined substantially. The Horizon Europe Research and Innovation Framework adopted by the European Parliament in April 2019 for the period 2021-2027 will serve as an important funding instrument for health research, yet the proposed health research budget to be finalised towards the end of 2019 was reduced from 10% in the current framework, Horizon 2020, to 8% in Horizon Europe. Our analysis takes the evolvement of Horizon Europe from the initial framework of June 2018 to the framework agreed on in April 2019 into account. It shows that despite some improvements in terms of Global Health and reference to the Sustainable Development Goals, European industrial competitiveness continues to play a paramount role, with Global Health research needs and relevant health research for LMICs being only partially addressed. We argue that the globally interconnected nature of health and the transdisciplinary nature of health research need to be fully taken into account and acted on in the new European Research and Innovation Framework. A facilitated global research collaboration through Horizon Europe could ensure that Global Health innovations and solutions benefit all parts of the world including EU countries. |
Note: | Reproducció del document publicat a: http://dx.doi.org/10.1136/bmjgh-2019-001559 |
It is part of: | BMJ Global Health, 2019, vol. 4, num. 5 |
URI: | http://hdl.handle.net/2445/144798 |
Related resource: | http://dx.doi.org/10.1136/bmjgh-2019-001559 |
ISSN: | 2059-7908 |
Appears in Collections: | Articles publicats en revistes (ISGlobal) Publicacions de projectes de recerca finançats per la UE |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Berner-RodoredaA_BMJ_Glob_Health_2019.pdf | 684.04 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License